Lexaria Bioscience Corp (LXX.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
(Values in thousands)
| 05-2026 | 02-2026 | 11-2025 | 08-2025 | 05-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,475 | 5,128 | 4,281 | 1,802 | 4,592 |
| Marketable Securities | 142 | 141 | 143 | 165 | 34 |
| Receivables | 49 | 42 | 88 | 368 | 358 |
| TOTAL | $4,065 | $5,770 | $5,363 | $3,468 | $5,807 |
| Non-Current Assets | |||||
| PPE Net | 313 | 335 | 316 | 335 | 354 |
| Intangibles | 339 | 318 | 308 | 308 | 516 |
| Other Non-Current Assets | 64 | 64 | 64 | 64 | 64 |
| TOTAL | $716 | $717 | $688 | $707 | $935 |
| Total Assets | $4,781 | $6,487 | $6,051 | $4,175 | $6,741 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 214 | 44 | 1,301 | 1,365 | 1,447 |
| TOTAL | $383 | $215 | $1,457 | $1,493 | $1,488 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 394 | 392 | 389 | 387 | 386 |
| TOTAL | $54 | $62 | $71 | $79 | $87 |
| Total Liabilities | $437 | $277 | $1,527 | $1,572 | $1,575 |
| Shareholders' Equity | |||||
| Common Shares | 25 | 25 | 22 | 20 | 20 |
| Retained earnings | -68,497 | -66,506 | -65,056 | -63,461 | -60,765 |
| Other shareholders' equity | -46 | -55 | -76 | -70 | -81 |
| TOTAL | $4,738 | $6,602 | $4,913 | $2,990 | $5,552 |
| Total Liabilities And Equity | $5,175 | $6,879 | $6,440 | $4,562 | $7,127 |